Literature DB >> 2549424

Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity.

G Graupner1, K N Wills, M Tzukerman, X K Zhang, M Pfahl.   

Abstract

Both thyroid hormone (T3) and retinoic acid signal essential steps in development, differentiation and morphogenesis. Specific nuclear receptors for these ligands have recently been cloned. Previously we have noted a close homology between the DNA-binding domains of the epsilon-retinoic acid receptor (RAR-epsilon, also designated RAR-beta), the thyroid hormone receptors and the oestrogen receptor. We have now found that RAR-epsilon is very efficient at inducing transcription from two distinct thyroid-hormone responsive elements (TREs). Transcription induced by ligand-activated RAR-epsilon from a TRE can, however, be repressed by thyroid-hormone receptor in the absence of its ligand. Conversely, in the presence of its ligand, thyroid-hormone receptor will activate transcription from a TRE irrespective of the presence of unbound RAR. The use of hybrid receptors has shown that the DNA-binding domain of RAR is the essential target for inhibition by thyroid-hormone receptors. These data, together with in vitro DNA-binding studies, suggest that thyroid-hormone receptors may have dual regulatory roles: in the presence of hormone they function as TRE-specific transcriptional activators; in the absence of hormone, however, they can function as TRE-specific repressors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549424     DOI: 10.1038/340653a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  78 in total

1.  Accumulation of different c-erbA transcripts during rat brain development and in cortical neurons cultured in a synthetic medium.

Authors:  D Castiglia; A Cestelli; C Di Liegro; L Bonfanti; I Di Liegro
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

2.  Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.

Authors:  J Bigler; W Hokanson; R N Eisenman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 3.  Nuclear thyroid hormone receptors.

Authors:  M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  The C'-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity.

Authors:  J M Holloway; C K Glass; S Adler; C A Nelson; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.

Authors:  B G Bonde; M Sharif; M L Privalsky
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 6.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

7.  A novel T-cell protein which recognizes a palindromic sequence in the negative regulatory element of the human immunodeficiency virus long terminal repeat.

Authors:  K Orchard; N Perkins; C Chapman; J Harris; V Emery; G Goodwin; D Latchman; M Collins
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.

Authors:  I Zamir; H P Harding; G B Atkins; A Hörlein; C K Glass; M G Rosenfeld; M A Lazar
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  Genomic organization of the retinoic acid receptor gamma gene.

Authors:  J M Lehmann; B Hoffmann; M Pfahl
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

10.  A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene.

Authors:  P C Lucas; R M O'Brien; J A Mitchell; C M Davis; E Imai; B M Forman; H H Samuels; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.